An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma

References

• Ouyang J, Wang Z, Yuan K, et al. Adjuvant lenvatinib plus PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy: a retrospective landmark analysis. J Hepatocell Carcinoma. 2023;10:1465–1477. doi:10.2147/JHC.S424616
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Orcutt ST, Anaya DA. Liver resection and surgical strategies for management of primary liver cancer. Cancer Control. 2018;25(1):1073274817744621. doi:10.1177/1073274817744621
   Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi:10.1016/j.jhep.2021.11.018
   PubMed Web of Science ®Google Scholar
• Ganesan P, Kulik LM. Hepatocellular carcinoma: new developments. Clin Liver Dis. 2023;27(1):85–102. doi:10.1016/j.cld.2022.08.004
   PubMed Web of Science ®Google Scholar
• Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–217. doi:10.1001/jamasurg.2018.4334
   PubMed Web of Science ®Google Scholar
• Zhang X, Li C, Wen T, et al. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. Eur J Gastroenterol Hepatol. 2015;27(8):933–940. doi:10.1097/MEG.0000000000000383
   PubMed Web of Science ®Google Scholar
• Tao C, Wu F, Wang H, et al. Clinical benefits of neoadjuvant radiotherapy on the postoperative recurrence of centrally located hepatocellular carcinoma: a real-world evidence based on Phase II clinical trial. J Hepatocell Carcinoma. 2023;10:753–764. doi:10.2147/JHC.S403287
   PubMed Web of Science ®Google Scholar
• Wicks JS, Dale BS, Ruffolo L, et al. Comparable and complimentary modalities for treatment of small-sized HCC: surgical resection, radiofrequency ablation, and microwave ablation. J Clin Med. 2023;12(15):5006. doi:10.3390/jcm12155006
   PubMed Web of Science ®Google Scholar
• Liao X, Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis. 2019;7(3):370–379. doi:10.1016/j.gendis.2019.10.016
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y, Zhang J, et al. Current perspective of traditional Chinese Medicines and active ingredients in the therapy of hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;9:41–56. doi:10.2147/JHC.S346047
   PubMed Web of Science ®Google Scholar
• Dai Y, Gao S, Liu X, et al. Effect of aidi injection plus TACE on hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:9196409. doi:10.1155/2018/9196409
   PubMedGoogle Scholar
• Hong XC, Liang QL, Luo XB, et al. Clinical study of XiangShaLiuJunZi decoction combined with S-1 as maintenance therapy for stage III or IV gastric carcinoma and colorectal carcinoma. Medicine. 2020;99(19):e20081. doi:10.1097/MD.0000000000020081
   PubMed Web of Science ®Google Scholar
• Huang L, Li H, Xie D, Shi T, Wen C. Personalizing Chinese medicine by integrating molecular features of diseases and herb ingredient information: application to acute myeloid leukemia. Oncotarget. 2017;8(26):43579–43591. doi:10.18632/oncotarget.16983
   PubMedGoogle Scholar
• Zheng Y, Zhang W, Xu L, Zhou H, Yuan M, Xu H. Recent progress in understanding the action of natural compounds at novel therapeutic drug targets for the treatment of liver cancer. Front Oncol. 2022;11:795548. doi:10.3389/fonc.2021.795548
   PubMed Web of Science ®Google Scholar
• Sun MY, Song YN, Zhang M, Zhang CY, Zhang LJ, Zhang H. Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9. Oncol Lett. 2019;17(1):965–973. doi:10.3892/ol.2018.9701
   PubMed Web of Science ®Google Scholar
• Zhang H, Tang QF, Sun MY, et al. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin. Cell Death Dis. 2018;9(9):916. doi:10.1038/s41419-018-0976-0
   PubMed Web of Science ®Google Scholar
• Yu T, Ye X, Wen Z, et al. Intraoperative indocyanine green retention test of left hemiliver in decision-making for patients with hepatocellular carcinoma undergoing right hepatectomy. Front Surg. 2021;8:709017. doi:10.3389/fsurg.2021.709017
   PubMed Web of Science ®Google Scholar
• Shi F, Fu Y, Wang J, et al. Trametenolic acid B triggers HSP90AA4P and autophagy in HepG2/2.2.15 cells by proteomic analysis. ACS Omega. 2020;5(22):13042–13051. doi:10.1021/acsomega.0c00962
   PubMed Web of Science ®Google Scholar
• Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol. 2018;4(3):182–190. doi:10.5114/ceh.2018.78122
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang XS, Pan F, et al. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation. Medicine. 2021;100(26):e26487. doi:10.1097/MD.0000000000026487
   PubMed Web of Science ®Google Scholar
• Huang D, Yang B, Yao Y, et al. Autophagic inhibition of Caveolin-1 by compound phyllanthus urinaria l. activates ubiquitination and proteasome degradation of β-catenin to suppress metastasis of hepatitis B-associated hepatocellular carcinoma. Front Pharmacol. 2021;12:659325. doi:10.3389/fphar.2021.659325
   PubMed Web of Science ®Google Scholar
• Isik B, Gonultas F, Sahin T, Yilmaz S. Microvascular venous invasion in hepatocellular carcinoma: why do recurrences occur? J Gastrointest Cancer. 2020;51(4):1133–1136. doi:10.1007/s12029-020-00487-9
   PubMed Web of Science ®Google Scholar
• He S, Fan X, Ma H, et al. Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy. Oncol Lett. 2019;18(2):1824–1830. doi:10.3892/ol.2019.10517
   PubMed Web of Science ®Google Scholar
• Bansal C, Gupta A, Kumar A, Srivastava A. Morphometric evaluation and clinical correlations in pediatric malignant small round cell tumors. Indian J Med Paediatr Oncol. 2014;35(4):267–270. doi:10.4103/0971-5851.144987
   PubMedGoogle Scholar
• Pan J, Zhang J, Hsia S-M. Research progress of PCNA in reproductive system diseases. Evid Based Complement Alternat Med. 2021;2021:2391917. doi:10.1155/2021/2391917
   PubMed Web of Science ®Google Scholar
• Eltawil KM, Kidd M, Giovinazzo F, Helmy AH, Salem RR. Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma. World J Surg Oncol. 2010;8(1):43. doi:10.1186/1477-7819-8-43
   PubMedGoogle Scholar
• Zeng ZM, Mo N, Zeng J, et al. Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol. 2022;14(9):1604–1621. doi:10.4251/wjgo.v14.i9.1604
   PubMed Web of Science ®Google Scholar
• Kim SH, Son SY, Park YS, Ahn SH, Park DJ, Kim HH. Risk factors for anastomotic leakage: a retrospective cohort study in a single gastric surgical unit. J Gastric Cancer. 2015;15(3):167–175. doi:10.5230/jgc.2015.15.3.167
   PubMed Web of Science ®Google Scholar
• Wang R, Liu Y, Sun H, et al. Estradiol is significantly associated with prognosis in non-surgical liver cancer patients: from bench to bedside. Aging. 2021;13(3):3483–3500. doi:10.18632/aging.202280
   PubMedGoogle Scholar
• Lin WC, Lin YS, Chang CW, et al. Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma. PLoS One. 2020;15(5):e0233212. doi:10.1371/journal.pone.0233212
   PubMed Web of Science ®Google Scholar
• Wei ZQ, Zhang YW. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit. Chin Med J. 2021;134(19):2275–2286. doi:10.1097/CM9.0000000000001767
   PubMed Web of Science ®Google Scholar
• Gao Z, Du G, Pang Y, et al. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine. 2017;96(33):e7426. doi:10.1097/MD.0000000000007426
   PubMed Web of Science ®Google Scholar
• Zhu GQ, Wang K, Wang B, et al. Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization. Cancer Manag Res. 2018;11:63–79. doi:10.2147/CMAR.S186150
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H, Huang Z, et al. Adjuvant lenvatinib after radical resection in patients with hepatocellular carcinoma(HCC): preliminary analysis of a prospective, multi‐center, single‐arm study. J Clin Oncol. 2022;40(S16):e16158. doi:10.1200/JCO.2022.40.16_suppl.e16158
   Google Scholar
• Chen Q, Shu C, Laurence AD, et al. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial. Gut. 2018;67(11):2006–2016. doi:10.1136/gutjnl-2018-315983
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang B, Chen XP. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Front Med. 2021;15(2):155–169. doi:10.1007/s11684-021-0848-3
   PubMed Web of Science ®Google Scholar
• Niu Y, Shan L, Gao H, et al. Huaier suppresses the hepatocellular carcinoma cell cycle by regulating minichromosome maintenance proteins. Onco Targets Ther. 2020;13:12015–12025. doi:10.2147/OTT.S279723
   PubMed Web of Science ®Google Scholar
• Yang X, Feng Y, Liu Y, et al. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway. Phytomedicine. 2021;87:153575. doi:10.1016/j.phymed.2021.153575
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun M, Yao W, et al. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib. J ImmunotherCancer. 2020;8(1):e000317. doi:10.1136/jitc-2019-000317
   Web of Science ®Google Scholar
• Wang N, Feng Y, Tan HY, et al. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma. J Ethnopharmacol. 2015;164:309–318. doi:10.1016/j.jep.2015.02.025
   PubMed Web of Science ®Google Scholar
• Cheng C, Shou Q, Lang J, et al. Gehua jiecheng decoction inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice by improving tumor immunosuppression microenvironment. Front Pharmacol. 2020;11:809. doi:10.3389/fphar.2020.00809
   PubMed Web of Science ®Google Scholar
• Wan LF, Shen JJ, Wang YH, et al. Extracts of Qizhu decoction inhibit hepatitis and hepatocellular carcinoma in vitro and in C57BL/6 mice by suppressing NF-κB signaling. SCI Rep. 2019;9(1):1415. doi:10.1038/s41598-018-38391-9
   PubMedGoogle Scholar
• Chou ST, Hsiang CY, Lo HY, et al. Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice. BMC Complement Altern Med. 2017;17(1):121. doi:10.1186/s12906-017-1586-6
   PubMed Web of Science ®Google Scholar
• Liang S, Zou Y, Gao J, et al. The Chinese Medicine, Jiedu Recipe, inhibits the epithelial mesenchymal transition of hepatocellular carcinoma via the regulation of Smad2/3 dependent and independent pathways. Evid Based Complement Alternat Med. 2018;2018:5629304. doi:10.1155/2018/5629304
   PubMed Web of Science ®Google Scholar
• Yu X, Lin XJ, Wang S, et al. Antitumor Efficacy of Huqizhengxiao (HQZX) decoction based on inhibition of telomerase activity in nude mice of hepatocarcinoma xenograft. Integr Cancer Ther. 2018;17(4):1216–1224. doi:10.1177/1534735418785999
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y, Zou Z, Li Y, Xie H, Yang H. Yin Yang Gong Ji pill is an ancient formula with antitumor activity against hepatoma cells. J Ethnopharmacol. 2020;248:112267. doi:10.1016/j.jep.2019.112267
   PubMed Web of Science ®Google Scholar
• Chen HW, Shen AL, Liu LY, Peng J, Chu JF. Bear Bile Powder Inhibits Growth of hepatocellular carcinoma via suppressing STAT3 signaling pathway in mice. Chin J Integr Med. 2020;26(5):370–374. doi:10.1007/s11655-019-3010-1
   PubMed Web of Science ®Google Scholar
• Fan D, Liu C, Li L, et al. Deciphering antitumor mechanism of Pien Tze Huang in mice of hepatocellular carcinoma based on proteomics. J Immunol Res. 2020;2020:4876251. doi:10.1155/2020/4876251
   PubMed Web of Science ®Google Scholar
• Lan HY, An P, Liu QP, et al. Aidi injection induces apoptosis of hepatocellular carcinoma cells through the mitochondrial pathway. J Ethnopharmacol. 2021;274:114073. doi:10.1016/j.jep.2021.114073
   PubMed Web of Science ®Google Scholar
• Cai Y, Du Q, Deng TH, et al. Huxie Huaji ointment induced apoptosis of liver cancer cells in vivo and in vitro by activating the mitochondrial pathway. Evid Based Complement Alternat Med. 2021;2021:9922059. doi:10.1155/2021/9922059
   PubMed Web of Science ®Google Scholar
• Xia J, Rong L, Sawakami T, et al. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma. Biomed Pharmacother. 2018;99:921–930. doi:10.1016/j.biopha.2018.01.163
   PubMed Web of Science ®Google Scholar
• Li M, Zhang M, Zhang ZL, et al. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB. Oncol Res. 2017;25(2):233–239. doi:10.3727/096504016X14742891049073
   PubMed Web of Science ®Google Scholar
• Li X, Yu H, Gong Y, Wu P, Feng Q, Liu C. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. J Ethnopharmacol. 2022;284:114801. doi:10.1016/j.jep.2021.114801
   PubMed Web of Science ®Google Scholar
• Feng XY, Chen BC, Li JC, et al. Gansui-Banxia Decoction extraction inhibits MDSCs accumulation via AKT /STAT3/ERK signaling pathways to regulate antitumor immunity in C57bl/6 mice. Phytomedicine. 2021;93:153779. doi:10.1016/j.phymed.2021.153779
   PubMed Web of Science ®Google Scholar
• Chen X, Cao Z, Zhang Y, et al. Fuzheng Qingjie granules inhibit growth of hepatoma cells via inducing mitochondria-mediated apoptosis and enhancing immune function. Integr Cancer Ther. 2017;16(3):329–338. doi:10.1177/1534735416654761
   PubMed Web of Science ®Google Scholar
• Shen Y, Yang F, Peng H, et al. Anti-tumor effect of Yanggan Huayu granule by inducing AKT-mediated apoptosis in hepatocellular carcinoma. J Ethnopharmacol. 2022;282:114601. doi:10.1016/j.jep.2021.114601
   PubMed Web of Science ®Google Scholar
• Hu B, Zhang T, An HM, Zheng JL, Yan X, Huang XW. Herbal formula YGJDSJ inhibits Anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells. BMC Complement Altern Med. 2018;18(1):17. doi:10.1186/s12906-018-2083-2
   PubMedGoogle Scholar
• Wu L, Zhao J, Cai H, et al. Dahuang Zhechong Pill combined with doxorubicin induces cell death through regulating energy metabolism in human hepatocellular carcinoma cells. Evid Based Complement Alternat Med. 2017;2017:6279576. doi:10.1155/2017/6279576
   PubMed Web of Science ®Google Scholar
• Wu HC, Lay IS, Shibu MA, et al. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice. Environ Toxicol Int J. 2017;32(9):2133–2143. doi:10.1002/tox.22426
   PubMed Web of Science ®Google Scholar
• Tan ZB, Fan HJ, Wu YT, et al. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. J Ethnopharmacol. 2019;232:62–72. doi:10.1016/j.jep.2018.12.019
   PubMed Web of Science ®Google Scholar
• Wang D, Yang C, Wang Z, et al. Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation. SCI Rep. 2017;7(1):9373. doi:10.1038/s41598-017-09668-2
   PubMedGoogle Scholar
• Guo Z, Zhou Y, Yang J, Shao X. Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/β-catenin signaling pathway. Biomed Pharmacother. 2019;110:371–379. doi:10.1016/j.biopha.2018.11.149
   PubMed Web of Science ®Google Scholar
• Wang R, Shao X, Yang J, Liu Z, Chew L, Shao Y. Ginkgo biloba extract mechanism inhibits hepatocellular carcinoma through the nuclear factor-κB/p53 signaling pathway. J Environ Pathol Toxicol Oncol. 2020;39(2):179–189. doi:10.1615/JEnvironPatholToxicolOncol.2020034510
   PubMed Web of Science ®Google Scholar
• Yuan P, Li J, Aipire A, et al. Cistanche tubulosa phenylethanoid glycosides induce apoptosis in H22 hepatocellular carcinoma cells through both extrinsic and intrinsic signaling pathways. BMC Complement Altern Med. 2018;18(1):275. doi:10.1186/s12906-018-2201-1
   PubMedGoogle Scholar
• Tsai JJ, Chen JH, Chen CH, Chung JG, Hsu FT. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo. Environ Toxicol Int J. 2020;35(2):167–175. doi:10.1002/tox.22853
   PubMed Web of Science ®Google Scholar
• Song YG, Kang L, Tian S, et al. Study on the anti-hepatocarcinoma effect and molecular mechanism of Prunella vulgaris total flavonoids. J Ethnopharmacol. 2021;273:113891. doi:10.1016/j.jep.2021.113891
   PubMed Web of Science ®Google Scholar
• Lin XL, Li K, Yang Z, Chen B, Zhang T. Dulcitol suppresses proliferation and migration of hepatocellular carcinoma via regulating SIRT1/p53 pathway. Phytomedicine. 2020;66:153112. doi:10.1016/j.phymed.2019.153112
   PubMed Web of Science ®Google Scholar
• Lu L, Liu S, Dong Q, Xin Y. Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway. Mol Med Rep. 2019;19(6):4964–4972. doi:10.3892/mmr.2019.10115
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao Y, Han H, Zou C, Feng Y, Zhang H. Matrine suppresses lung metastasis of human hepatocellular carcinoma by directly targeting matrix metalloproteinase-9. Biochem Biophys Res Commun. 2019;515(1):57–63. doi:10.1016/j.bbrc.2019.04.063
   PubMed Web of Science ®Google Scholar
• Le J, Fu Y, Han Q, et al. Transcriptome analysis of the inhibitory effect of sennoside A on the metastasis of hepatocellular carcinoma cells. Front Pharmacol. 2021;11:566099. doi:10.3389/fphar.2020.566099
   PubMed Web of Science ®Google Scholar
• Ye Y, Song Y, Zhuang J, Wang G, Ni J, Xia W. Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells. J Cell Physiol. 2019;234(2):1880–1888. doi:10.1002/jcp.27063
   PubMed Web of Science ®Google Scholar
• Sun Y, Tan YJ, Lu ZZ, et al. Arctigenin inhibits liver cancer tumorigenesis by inhibiting gankyrin expression via C/EBPα and PPARα. Front Pharmacol. 2018;9:268. doi:10.3389/fphar.2018.00268
   PubMed Web of Science ®Google Scholar
• Sohretoglu D, Shile H. Ganoderma lucidum polysaccharides as an anti-cancer agent. Anti Cancer Agents Med Chem. 2018;18(5):667–674. doi:10.2174/1871520617666171113121246
   PubMed Web of Science ®Google Scholar
• Mo Z, Cao Z, Yu L, et al. An integrative analysis reveals the potential mechanism between Herbal Medicine Yinchen and immunoregulation in hepatocellular carcinoma. Biomed Res Int. 2020;2020:8886914. doi:10.1155/2020/8886914
   PubMed Web of Science ®Google Scholar
• Qi X, Wang L, Wang H, Yang L, Li X, Wang L. Aconitine inhibits the proliferation of hepatocellular carcinoma by inducing apoptosis. Int J Clin Exp Pathol. 2018;11(11):5278–5289.
   PubMed Web of Science ®Google Scholar
• Li NN, Meng XS, Men WX, Bao YR, Wang S. Total flavonoids from oroxylum indicum induce apoptosis via PI3K/Akt/PTEN signaling pathway in liver cancer. Evid Based Complement Alternat Med. 2018;2018:3021476. doi:10.1155/2018/3021476
   PubMed Web of Science ®Google Scholar
• Bi L, Yan X, Chen W, Gao J, Qian L, Qiu S. Antihepatocellular carcinoma potential of tetramethylpyrazine induces cell cycle modulation and mitochondrial-dependent apoptosis: regulation of p53 signaling pathway in HepG2 cells in vitro. Integr Cancer Ther. 2016;15(2):226–236. doi:10.1177/1534735416637424
   PubMed Web of Science ®Google Scholar
• Liu T, Tian L, Fu X, Wei L, Li J, Wang T. Saffron inhibits the proliferation of hepatocellular carcinoma via inducing cell apoptosis. Panminerva Med. 2020;62(1):7–12. doi:10.23736/S0031-0808.18.03561-9
   PubMed Web of Science ®Google Scholar
• Lei Y, Gan H, Huang Y, et al. Digitoxin inhibits proliferation of multidrug-resistant HepG2 cells through G2/M cell cycle arrest and apoptosis. Oncol Lett. 2020;20(4):71. doi:10.3892/ol.2020.11932
   PubMed Web of Science ®Google Scholar
• Tan HY, Wang N, Tsao SW, Zhang Z, Feng Y Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in coptidis rhizome in hepatocellular carcinoma. Integr Cancer Ther. 2014;13(5):425–43.
   PubMed Web of Science ®Google Scholar
• Shi L, Zhang G, Zheng Z, Lu B, Ji L. Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1: the involvement of JNK and MTA1/HDCA. Chem Biol Interact. 2017;273:228–236. doi:10.1016/j.cbi.2017.06.024
   PubMed Web of Science ®Google Scholar
• Tang D, Zhang S, Shi X, et al. Combination of astragali polysaccharide and curcumin improves the morphological structure of tumor vessels and induces tumor vascular normalization to inhibit the growth of hepatocellular carcinoma. Integr Cancer Ther. 2019;18:1534735418824408. doi:10.1177/1534735418824408
   Web of Science ®Google Scholar
• Qu J, Lu W, Chen M, et al. Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer. EXP Ther Med. 2020;20(5):18. doi:10.3892/etm.2020.9145
   PubMed Web of Science ®Google Scholar
• Tian S, Liao L, Zhou Q, et al. Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues. Oncol Lett. 2021;21(4):286. doi:10.3892/ol.2021.12547
   PubMed Web of Science ®Google Scholar
• Hu P, Ke C, Guo X, et al. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma. Dig Liver Dis. 2019;51(1):120–126. doi:10.1016/j.dld.2018.06.012
   PubMedGoogle Scholar
• Zhang G, Zeng X, Zhang R, et al. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3. Phytomedicine. 2016;23(12):1329–1336. doi:10.1016/j.phymed.2016.07.003
   PubMed Web of Science ®Google Scholar
• Li F, Wang J, Wu N, Zhang H, Li Z, Wei N. H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA. Biochem Biophys Res Commun. 2019;520(1):93–98. doi:10.1016/j.bbrc.2019.09.082
   PubMed Web of Science ®Google Scholar
• Yu Y, Qian L, Du N, Liu Y, Zhao X, Zhang X. Ganoderma lucidum polysaccharide enhances radiosensitivity of hepatocellular carcinoma cell line HepG2 through Akt signaling pathway. Exp Ther Med. 2017;14(6):5903–5907. doi:10.3892/etm.2017.5340
   PubMed Web of Science ®Google Scholar
• Tian YD, Lin S, Yang PT, et al. Saikosaponin-d increases the radiosensitivity of hepatoma cells by adjusting cell autophagy. J Cancer. 2019;10(20):4947–4953. doi:10.7150/jca.30286
   PubMed Web of Science ®Google Scholar
• Zhang CY, Jiang ZM, Ma XF, et al. Saikosaponin-d inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under Hypoxia. Front Pharmacol. 2019;10:1039. doi:10.3389/fphar.2019.01039
   PubMed Web of Science ®Google Scholar
• Yu L, Jiang B, Chen Z, et al. Cytisine induces endoplasmic reticulum stress caused by calcium overload in HepG2 cells. OncolRep. 2018;39(3):1475–1484. doi:10.3892/or.2018.6200
   Web of Science ®Google Scholar
• Deng LJ, Lei YH, Quan JY, et al. 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. J Ethnopharmacol. 2021;266:113443. doi:10.1016/j.jep.2020.113443
   PubMed Web of Science ®Google Scholar
• Yu Z, Feng H, Sun X, et al. Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase. Sci Rep. 2018;8(1):3891. doi:10.1038/s41598-018-22113-2
   PubMed Web of Science ®Google Scholar
• Liu K, Tian T, Zheng Y, et al. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway. J Cell Mol Med. 2019;23(4):3040–3044. doi:10.1111/jcmm.14169
   PubMed Web of Science ®Google Scholar
• Gao Y, Chu S, Shao Q, et al. Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice. Free Radic Res. 2017;51(1):1–13. doi:10.1080/10715762.2016.1234710
   PubMed Web of Science ®Google Scholar
• Qian YY, Li WY, Yan Y, et al. Celastrus orbiculatus extracts inhibit human hepatocellular carcinoma growth by targeting mTOR signaling pathways. Chin J Integr Med. 2019;25(11):845–852. doi:10.1007/s11655-019-3035-5
   PubMed Web of Science ®Google Scholar
• Hsu WC, Ramesh S, Shibu MA, et al. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation. Phytomedicine. 2021;82:153442. doi:10.1016/j.phymed.2020.153442
   PubMed Web of Science ®Google Scholar
• Guo Z, Chen W, Dai G, Huang Y. Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med. 2020;45(1):141–150. doi:10.3892/ijmm.2019.4391
   PubMed Web of Science ®Google Scholar
• Qi F, Wang J, Zhao L, Cai P, Tang W, Wang Z. Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway. Biosci Trends. 2018;12(3):291–297. doi:10.5582/bst.2018.01082
   PubMed Web of Science ®Google Scholar
• Shan L, Li Y, Jiang H, et al. Huaier restrains proliferative and migratory potential of hepatocellular carcinoma cells partially through decreased Yes-Associated Protein 1. J Cancer. 2017;8(19):4087–4097. doi:10.7150/jca.21018
   PubMed Web of Science ®Google Scholar
• Han H, Wang L, Liu Y, et al. Combination of curcuma zedoary and kelp inhibits growth and metastasis of liver cancer in vivo and in vitro via reducing endogenous H2S levels. Food Funct. 2019;10(1):224–234. doi:10.1039/c8fo01594e
   PubMed Web of Science ®Google Scholar
• Zhao J, Lin W, Cao Z, et al. Total alkaloids of Rubus aleaefolius Poir. Inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma. Oncol Rep. 2013;30(3):1309–1314. doi:10.3892/or.2013.2585
   PubMed Web of Science ®Google Scholar
• Wang XB, Wu DJ, Chen WP, Liu J, Ju YJ. Impact of radiotherapy on immunological parameters, levels of inflammatory factors, and clinical prognosis in patients with esophageal cancer. J Radiat Res. 2019;60(3):353–363. doi:10.1093/jrr/rrz006
   PubMed Web of Science ®Google Scholar
• Sena P, Mancini S, Bertacchini J, Carnevale G, Pedroni M, Roncucci L. Autoimmunity profiles as prognostic indicators in patients with colorectal cancer versus those with cancer at other sites: a prospective study. Cancers. 2021;13(13):3239. doi:10.3390/cancers13133239
   PubMed Web of Science ®Google Scholar
• Chen PC, Chen CC, Ker YB, Chang CH, Chyau CC, Hu ML. Anti-metastatic effects of antrodan with and without cisplatin on Lewis lung carcinomas in a Mouse Xenograft Model. Int J Mol Sci. 2018;19(6):1565. doi:10.3390/ijms19061565
   PubMed Web of Science ®Google Scholar
• Klimaszewska-Wiśniewska A, Grzanka D, Czajkowska P, et al. Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells. Int J Oncol. 2019;55(6):1261–1274. doi:10.3892/ijo.2019.4889
   PubMed Web of Science ®Google Scholar
• Su YS, Kuo MZ, Kuo YT, et al. Diterpenoid anthraquinones as chemopreventive agents altered microRNA and transcriptome expressions in cancer cells. Biomed Pharmacother. 2021;136:111260. doi:10.1016/j.biopha.2021.111260
   PubMed Web of Science ®Google Scholar
• Wu DL, Liao ZD, Chen FF, et al. Benzophenones from Anemarrhena asphodeloides Bge. Exhibit anticancer activity in HepG2 cells via the NF-κB signaling pathway. Molecules. 2019;24(12):2246. doi:10.3390/molecules24122246
   PubMed Web of Science ®Google Scholar
• Shi J, Wang L, Lu Y, et al. Protective effects of sea buckthorn pulp and seed oils against radiation-induced acute intestinal injury. J Radiat Res. 2017;58(1):24–32. doi:10.1093/jrr/rrw069
   PubMed Web of Science ®Google Scholar
• Yin Z, Chen D, Liang S, Li X. Neoadjuvant therapy for hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;9:929–946. doi:10.2147/JHC.S357313
   PubMed Web of Science ®Google Scholar
• Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002 Nov;3(11):991–8
   PubMed Web of Science ®Google Scholar
• Zheng S, Asnani M, Thomas-Tikhonenko A, et al. Escape from ALL-CARTaz: leukemia immunoediting in the age of chimeric antigen receptors. Cancer Journal. 2019;25(3):217–222. doi:10.1097/PPO.0000000000000381
   PubMed Web of Science ®Google Scholar
• Yu D, Guang YA. Clinical effects of Xihuang Pill combined with chemotherapy in patients with advanced colorectal cancer. Evid Based Complement Altern Med. 2017;2017:5936086. doi:10.1155/2017/5936086
   PubMed Web of Science ®Google Scholar
• Xia D, Li W, Tang C, Jiang J. Astragaloside IV, as a potential anticancer agent. Front Pharmacol. 2023;14:1065505. doi:10.3389/fphar.2023.1065505
   PubMed Web of Science ®Google Scholar
• Hu J, Jiao J, Wang Y, et al. Effect of extract from ginseng rust rot on the inhibition of human hepatocellular carcinoma cells in vitro. Micron. 2019;124:102710. doi:10.1016/j.micron.2019.102710
   PubMed Web of Science ®Google Scholar
• Gerardi G, Rivero-Pérez MD, Cavia-Saiz M, et al. Wine Pomace Product Inhibit Listeria monocytogenes invasion of intestinal cell lines Caco-2 and SW-480. Foods. 2021;10(7):1485. doi:10.3390/foods10071485
   PubMed Web of Science ®Google Scholar
• Gong G, Liu Q, Deng Y, et al. Arabinogalactan derived from Lycium barbarum fruit inhibits cancer cell growth via cell cycle arrest and apoptosis. Int J Biol Macromol. 2020;149:639–650. doi:10.1016/j.ijbiomac.2020.01.251
   PubMed Web of Science ®Google Scholar
• Liu JS, Huo CY, Cao HH, et al. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway [published correction appears in Phytomedicine. 2021 Nov;92:153731]. Phytomedicine. 2019;61:152843. doi:10.1016/j.phymed.2019.152843
   PubMed Web of Science ®Google Scholar
• Ma L, Jiang H, Xu X, et al. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway. Aging. 2019;11(21):9719–9737. doi:10.18632/aging.102420
   PubMedGoogle Scholar
• Wen B, Wei YT, Mu LL, Wen GR, Zhao K. The molecular mechanisms of celecoxib in tumor development. Medicine. 2020;99(40):e22544. doi:10.1097/MD.0000000000022544
   PubMed Web of Science ®Google Scholar
• Di W, Li F, He L, et al. A transcription factor DAF-5 functions in Haemonchus contortus development. Parasit Vectors. 2021;14(1):529. doi:10.1186/s13071-021-05036-2
   PubMed Web of Science ®Google Scholar
• Sheng J, Zou X, Cheng Z, et al. Recent advances in herbal medicines for digestive system malignancies. Front Pharmacol. 2018;9:1249. doi:10.3389/fphar.2018.01249
   PubMed Web of Science ®Google Scholar
• Pretzsch E, Bösch F, Neumann J, et al. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol. 2019;2019:7407190. doi:10.1155/2019/7407190
   PubMed Web of Science ®Google Scholar
• El Khoury D, Matar R, Touma T. Curcumin and endometrial carcinoma: an old spice as a novel agent. Int J Womens Health. 2019;11:249–256. doi:10.2147/IJWH.S194262
   PubMed Web of Science ®Google Scholar
• Yang YSH, Li ZL, Shih YJ, et al. Herbal medicines attenuate PD-L1 expression to induce anti-proliferation in obesity-related cancers. Nutrients. 2019;11(12):2979. doi:10.3390/nu11122979
   PubMed Web of Science ®Google Scholar
• Shao Y, Zhu W, Da J, et al. Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer. Onco Targets Ther. 2017;10:2675–2683. doi:10.2147/OTT.S130653
   PubMed Web of Science ®Google Scholar
• Tu SP, Jin H, Shi JD, et al. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res. 2012;5(2):205–215. doi:10.1158/1940-6207.CAPR-11-0247
   PubMed Web of Science ®Google Scholar
• Cheng-En H, Gan J, Zhang R-D, et al. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand J Gastroenterol. 2011;46(2):156–164. doi:10.3109/00365521.2010.516450
   PubMed Web of Science ®Google Scholar
• Helgadottir H, Rocha Trocoli Drakensjö I, Girnita A. Personalized medicine in malignant melanoma: towards patient tailored treatment. Front Oncol. 2018;8:202. doi:10.3389/fonc.2018.00202
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu X. Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor-promoting factors (Review). Oncol Rep. 2021;46(2):184. doi:10.3892/or.2021.8135
   PubMed Web of Science ®Google Scholar
• Lyu SY, Choi SH, Park WB. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch Pharmacal Res. 2002;25(1):93–101. doi:10.1007/BF02975269
   PubMed Web of Science ®Google Scholar
• Yang P, Jiang Y, Pan Y, et al. Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression. Sci Rep. 2019;9(1):6428. doi:10.1038/s41598-019-41444-2
   PubMedGoogle Scholar
• Park S-Y, Lee C-J, Choi J-H, et al. The JAK2/STAT3/CCND2 Axis promotes colorectal cancer stem cell persistence and radioresistance. J Exper Clin Cancer Res. 2019;38(1):399. doi:10.1186/s13046-019-1405-7
   PubMed Web of Science ®Google Scholar
• uang C, Xiang Y, Chen S, et al. Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer. Cancer Sci. 2017;108(11):2130–2141. doi:10.1111/cas.13347
   PubMed Web of Science ®Google Scholar
• Wang B, Min W, Lin S, et al. Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation. Int J Med Sci. 2021;18(6):1465–1473. doi:10.7150/ijms.53024
   PubMed Web of Science ®Google Scholar
• Zhang B, Shi D, Zhang X, Liang G, Liu W, Qiao S. FK866 inhibits the epithelial-mesenchymal transition of hepatocarcinoma MHCC97-H cells. Oncol Lett. 2018;16(6):7231–7238. doi:10.3892/ol.2018.9541
   PubMed Web of Science ®Google Scholar
• Shamay Y, Shah J, Işık M, et al. Quantitative self-assembly prediction yields targeted nanomedicines. Nat Mater. 2018;17(4):361–368. doi:10.1038/s41563-017-0007-z
   PubMed Web of Science ®Google Scholar
• Tang W, Chen Z, Zhang W, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. doi:10.1038/s41392-020-0187-x
   PubMed Web of Science ®Google Scholar
• Abdul-Hafez A, Mohamed T, Omar H, Shemis M, Uhal BD. The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis. J Lung Pulm Respir Res. 2018;5(1):00160.
   PubMedGoogle Scholar
• Su J, Liao D, Su Y, et al. Novel polysaccharide extracted from Sipunculus nudus inhibits HepG2 tumour growth in vivo by enhancing immune function and inducing tumour cell apoptosis. J Cell Mol Med. 2021;25(17):8338–8351. doi:10.1111/jcmm.16793
   PubMed Web of Science ®Google Scholar
• Wu R, Liang Y, Xu M, et al. Advances in chemical constituents, clinical applications, pharmacology, pharmacokinetics and toxicology of Erigeron breviscapus. Front Pharmacol. 2021;12:656335. doi:10.3389/fphar.2021.656335
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu F, Yu JJ, Jin JZ. β-Bourbonene attenuates proliferation and induces apoptosis of prostate cancer cells. Oncol Lett. 2018;16(4):4519–4525. doi:10.3892/ol.2018.9183
   PubMed Web of Science ®Google Scholar
• Liu Z, Ren B, Wang Y, et al. Sesamol induces human hepatocellular carcinoma cells apoptosis by impairing mitochondrial function and suppressing autophagy. Sci Rep. 2017;7(1):45728. doi:10.1038/srep45728
   PubMedGoogle Scholar
• Choudhary HB, Mandlik SK, Mandlik DS. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World J Gastrointest Pathophysiol. 2023;14(3):46–70. doi:10.4291/wjgp.v14.i3.46
   PubMedGoogle Scholar
• Li H, Ruan WJ, Liu LQ, et al. Impact of Taurine on the proliferation and apoptosis of human cervical carcinoma cells and its mechanism. Chin Med J. 2019;132(8):948–956. doi:10.1097/CM9.0000000000000162
   PubMed Web of Science ®Google Scholar
• Wang QS, Gao LN, Zhu XN, et al. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma. Theranostics. 2019;9(21):6239–6255. doi:10.7150/thno.35972
   PubMed Web of Science ®Google Scholar
• Shu Y, Yang Y, Zhao Y, et al. Melittin inducing the apoptosis of renal tubule epithelial cells through upregulation of Bax/Bcl-2 expression and activation of TNF-α signaling pathway. Biomed Res Int. 2019;2019:9450368. doi:10.1155/2019/9450368
   PubMed Web of Science ®Google Scholar
• Londono C, Osorio C, Gama V, Alzate O. Mortalin, apoptosis, and neurodegeneration. Biomolecules. 2012;2(1):143–164. doi:10.3390/biom2010143
   PubMedGoogle Scholar
• Zhou C, Luo Y, Lei Z, Wei G. UHPLC-ESI-MS analysis of purified flavonoids fraction from stem of dendrobium denneaum paxt. and its preliminary study in inducing apoptosis of HepG2 cells. Evid Based Complement Alternat Med. 2018;2018:8936307. doi:10.1155/2018/8936307
   PubMed Web of Science ®Google Scholar
• Yu B, Wang AH, Zhou K, Chai LJ, Liu L. Molecular pathway of psoralidin-induced apoptosis in HepG2 cell line. Chin J Integr Med. 2019;25(10):757–762. doi:10.1007/s11655-016-2251-5
   PubMed Web of Science ®Google Scholar
• Wang X, Peng P, Pan Z, Fang Z, Lu W, Liu X. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52(1):34. doi:10.1186/s40659-019-0241-8
   PubMed Web of Science ®Google Scholar
• Tan J, Sun X, Wang S, et al. Evaluation of angiogenesis and pathological classification of extrahepatic cholangiocarcinoma by dynamic MR imaging for E-Healthcare. J Healthc Eng. 2021;2021:8666498. doi:10.1155/2021/8666498
   PubMed Web of Science ®Google Scholar
• Liu M, Li H, Wang X, Jing L, Jiang P, Li Y. Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer-bearing mice and patients. Cancer Med. 2020;9(8):2660–2673. doi:10.1002/cam4.2923
   PubMed Web of Science ®Google Scholar
• Raineri EJM, Yedavally H, Salvati A, van Dijl JM. Time-resolved analysis of Staphylococcus aureus invading the endothelial barrier. Virulence. 2020;11(1):1623–1639. doi:10.1080/21505594.2020.1844418
   PubMed Web of Science ®Google Scholar
• Sneddon JB, Tang Q, Stock P, et al. Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell. 2018;22(6):810–823. doi:10.1016/j.stem.2018.05.016
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Rashid MH, et al. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis. Oncotarget. 2017;8(31):51591–51607. doi:10.18632/oncotarget.18196
   PubMedGoogle Scholar
• Zhang H, Wu Z, Hu D, et al. Immunotherapeutic targeting of NG2/CSPG4 in solid organ cancers. Vaccines. 2022;10(7):1023. doi:10.3390/vaccines10071023
   Web of Science ®Google Scholar
• Li C-F, Pan Y-K, Gao Y, et al. Autophagy protects HUVECs against ER stress-mediated apoptosis under simulated microgravity. Apoptosis. 2019;24(9–10):812–825. doi:10.1007/s10495-019-01560-w
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang J, Xue H, et al. Nitidine chloride is a potential alternative therapy for glioma through inducing endoplasmic reticulum stress and alleviating epithelial-mesenchymal transition. Integr Cancer Ther. 2020;19:1534735419900927. doi:10.1177/1534735419900927
   Web of Science ®Google Scholar
• Liu Y-H, Weng Y-P, Lin H-Y, et al. Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells. Sci Rep. 2017;7(1):41437. doi:10.1038/srep41437
   PubMedGoogle Scholar
• Wen D, Liu W-L, Lu Z-W, et al. SNHG9, a papillary thyroid cancer cell exosome-enriched lncRNA, inhibits cell autophagy and promotes cell apoptosis of normal thyroid epithelial cell Nthy-ori-3 through YBOX3/P21 pathway. Front Oncol. 2021;11:647034. doi:10.3389/fonc.2021.647034
   PubMed Web of Science ®Google Scholar